Company profile: DDL
1.1 - Company Overview
Company description
- Provider of diagnostic solutions in molecular virology, bioinformatics, molecular bacteriology, and pathology, supporting clinical trials globally across five continents. Offers infectious disease and vaccine development expertise, oncology trial support, rare disease cell and gene therapy operations, biologics and biosimilars services from preclinical to post-market, and customized kit building for sample integrity.
Products and services
- Oncology: Supports complex oncology trials using industry-leading labs, patient databases, and a network of scientific experts, delivering lab-led trial support with patient database utilization and expert collaboration
- Clinical Trial Services: Delivers multi-continental clinical trial support through a global logistical and laboratory network covering five continents, enabling worldwide access to logistics and laboratory capabilities
- Infectious Disease & Vaccine Development: Constructs infrastructure-backed initiatives with operational expertise and logistical infrastructure to characterize, research, and treat emerging infectious diseases
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DDL
Achillion Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies targeting the complement system, including Soliris for paroxysmal nocturnal haemoglobinuria (PNH), atypical haemolytic uraemic syndrome (aHUS) and neuromyelitis optica spectrum disorder; Ultomiris, a long-acting C5 complement inhibitor, for PNH, aHUS, generalised myasthenia gravis and NMOSD; and Strensiq for hypophosphatasia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Achillion Pharmaceuticals company profile →
Great Basin Scientific
HQ: United States
Website
- Description: Provider of molecular, rapid diagnostic testing solutions, featuring the Great Basin Diagnostic System, a fully automated sample-to-result platform with integrated reagents and internal controls. Offers assays including Staph ID/R Blood Culture Panel, Stool Bacterial Pathogens, C. diff, Group B Strep, and Shiga Toxin Direct tests.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Great Basin Scientific company profile →
Eurocine Vaccines
HQ: United States
Website
- Description: Provider of nasal flu vaccines for children and the elderly, managing preclinical and clinical development, scalability into manufacturing, business development, and funding. Offers Endocine, a nasal vaccine adjuvant used in clinical trials showing safety and tolerability in over 400 human subjects; an HSV-2 therapeutic vaccine candidate; and vaccine development services from conceptualization to commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurocine Vaccines company profile →
RQx Pharmaceuticals
HQ: United States
Website
- Description: Provider of broad spectrum antibiotic development; a biopharmaceutical company founded in 2010 and based in La Jolla, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RQx Pharmaceuticals company profile →
Viamet Pharmaceuticals
HQ: United States
Website
- Description: Provider of small molecule inhibitors of validated metalloenzymes developed via a proprietary metal-binding approach (Metallophile Technology) for the treatment of various diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viamet Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DDL
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DDL
2.2 - Growth funds investing in similar companies to DDL
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DDL
4.2 - Public trading comparable groups for DDL
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →